Immunosuppressants Flashcards
Toxicities of sirolimus (rapamycin)
Hyperlipidemia, Anemia, Leukopenia, Thrombocytopenia, Fever, GI effects
CyclosporineA
1) BLOCKS calcineurin (phosphatase) -> Activates Tx of IL-2R genes
Acts on T cells to inhibit TCR activation and Cytokine Induction
2) BLOCKS IgE mediated mast cell degranulation
3) STIMULATES TGF-beta expression: Inhibitory cytokine
**KIDNEY TOXICITY
Tacrolimus (FK506)
BLOCKS calcineurin used for IL-2R Tx activation
Acts on T cells to inhibit TCR activation and induction of cytokines
FKBP/FK506 Complex binds to and blocks calcineurin
**Same action as CsA but used as an alternative since it does not have kidney toxicity
Two drugs that can bind to FKBP12 to prevent action of calcineurin
Tacrolimus (FK506)
Sirolimus (rapamycin)
Tacrolimus
FK506
Sirolimus
Rapamycin
Two drugs that block calcineurin
CsA + Tacrolimus (FK506)
Immunosuppressant Drugs that blocks T cell proliferation (IL-2)
1) mTOR inhibitors (Sirolimus and Everolimus)
2) Cytotoxic Drugs that inhibit Purine biosynthesis (Azathioprine, Mycophenolate Mofetil)
3) Dacluizmab - Prevents binding of IL-2 to its receptor
Drug (acts like CTLA4-IgG) - Binds CD80(B7)/CD86 [APC] and prevents it from binding to CD28 (Tcell)
Abatacept [CTLA4-IgG]
Another R.A. drug that acts as an anti-TNFalpha agent
Adalimumab (Humira)
Sirolimus (Rapamycin)
T cell blocker by BLOCKING mTOR kinase (Needed for cytokine signaling)
Prophylaxis of organ rejection
Used with Calcineurin inhibitors and glucocorticoids